Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001104659-25-052632
Filing Date
2025-05-27
Accepted
2025-05-27 06:09:04
Documents
20

Document Format Files

Seq Description Document Type Size
1 FORM PRER14A tm2515182-3_prer14a.htm   iXBRL PRER14A 703512
4 GRAPHIC lg_entero-4clr.jpg GRAPHIC 10965
5 GRAPHIC bc_tsr-4c.jpg GRAPHIC 48422
6 GRAPHIC bc_netloss-4c.jpg GRAPHIC 62671
7 GRAPHIC px_25enteroproxy1pg01-bw.jpg GRAPHIC 276085
8 GRAPHIC px_25enteroproxy1pg02-bw.jpg GRAPHIC 188997
  Complete submission text file 0001104659-25-052632.txt   2843444

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ento-20241231.xsd EX-101.SCH 9050
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ento-20241231_lab.xml EX-101.LAB 33989
23 EXTRACTED XBRL INSTANCE DOCUMENT tm2515182-3_prer14a_htm.xml XML 155243
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
Entero Therapeutics, Inc. (Filer) CIK: 0001604191 (see all company filings)

EIN.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRER14A | Act: 34 | File No.: 001-37853 | Film No.: 25984097
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)